Comparison · NCT02130570-f3c54d26
Multi-Model Intensive Discharge Program vs Usual Care: Number of Patients With a Nonelective Readmission Within 30 Days of the Index Discharge Date
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Multi-Model Intensive Discharge Program vs Usual Care: Number of Patients With a Nonelective Readmission Within 30 Days of the Index Discharge Date. Trial comparisons, record NCT02130570-f3c54d26. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02130570-f3c54d26
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.109 | 0.0914 | 0.131 | wilson | |
| Risk in group 2 | 0.115 | 0.093 | 0.141 | wilson | |
| Risk difference, group 1 minus group 2 | -0.00547 | -0.0373 | 0.0249 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.952 | 0.723 | 1.25 | log | |
| Odds ratio, group 1 over group 2 | 0.947 | 0.694 | 1.29 | log | |
| Number needed to treat, for one fewer participant with the outcome on Multi-Model Intensive Discharge Program than on Usual Care | 183 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: usual care.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Multi-Model Intensive Discharge Program | Multi-Model Intensive Discharge Intervention: 1. Inpatient medication safety interventions 2. Inpatient discharge advocate 3. Structured visiting nurse (VNA) appointments 4. Post-discharge phone call by primary care personnel within 2 business days of discharge 5. Structured post-discharge clinic appointment with PCP and other PCMH personnel within 2 weeks of discharge 6. Improved communication between inpatient and primary care teams 7. High-risk patients will receive additional interventions as needed:~1. Home pharmacist visit~2. Enrollment in the Partners integrated Care Management Program (iCMP)~3. Enrollment in telemedicine programs for patients with CHF~4. Palliative care consultation regarding goals of care 8. Novel health information technology to facilitate communication and transfer of clinical information | 107 | 978 | OG000 |
| Group 2 | Usual Care | Patients receive the care they would normally receive. | 78 | 679 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Patients With a Nonelective Readmission Within 30 Days of the Index Discharge Date
- Description
- Nonelective readmission within 30 days of the index discharge date
- Time frame
- 30 days after discharge
- Population
1679 participants were enrolled in the study, however, 22 patients were lost to follow-up and therefore not included in the analysis (e.g., patient withdrew consent, patient died during index admission).
Source ClinicalTrials.gov
Trial
- Title
- Relative Patient Benefits of a Hospital-PCMH Collaboration Within an ACO to Improve Care Transitions
- NCT number
- NCT02130570
- Phases
- NA
- Conditions
- Adverse Events, Readmissions, Patient Engagement
- Interventions
- Multi-Model Intensive Discharge Intervention
- Lead sponsor
- Brigham and Women's Hospital
- Results first posted
- 2019-08-20
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT02130570?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT02130570-f3c54d26